🚀 VC round data is live in beta, check it out!
BibbInstruments Valuation Multiples
Discover revenue and EBITDA valuation multiples for BibbInstruments and similar public comparables like Zynex, AMA Corp, enVVeno Medical, Bioretec and more.
BibbInstruments Overview
About BibbInstruments
BibbInstruments AB develops disposable biopsy instrumentation under the brand EndoDrill for early detection of cancer tumors, especially in deep-tissue tumors. The product portfolio includes six disposable instruments based on the patented EndoDrill technology and a novel biopsy method still under development. The instruments will be used for tissue sampling (biopsy) of the most common types of cancer, for example; lung, breast, colorectal, prostate and stomach cancer.
Founded
2013
HQ
Employees
5
Website
Sectors
Financials (FY)
EV
$7M
BibbInstruments Financials
BibbInstruments reported last fiscal year revenue of $44K and negative EBITDA of ($1M).
In the same fiscal year, BibbInstruments generated $7K in gross profit, ($1M) in EBITDA losses, and had net loss of ($2M).
BibbInstruments P&L
In the most recent fiscal year, BibbInstruments reported revenue of $44K and EBITDA of ($1M).
BibbInstruments expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $44K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $7K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 16% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (3270%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (3658%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (3643%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
BibbInstruments Stock Performance
BibbInstruments has current market cap of $8M, and enterprise value of $7M.
Market Cap Evolution
BibbInstruments' stock price is $0.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7M | $8M | 0.3% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBibbInstruments Valuation Multiples
BibbInstruments trades at 167.0x EV/Revenue multiple, and (5.1x) EV/EBITDA.
BibbInstruments Financial Valuation Multiples
As of April 20, 2026, BibbInstruments has market cap of $8M and EV of $7M.
Equity research analysts estimate BibbInstruments' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
BibbInstruments has a P/E ratio of (5.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8M | XXX | $8M | XXX | XXX | XXX |
| EV (current) | $7M | XXX | $7M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 167.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (5.1x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (4.6x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1030.4x | XXX | XXX | XXX |
| P/E | — | XXX | (5.0x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (3.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified BibbInstruments Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
BibbInstruments Margins & Growth Rates
BibbInstruments' revenue in the last fiscal year grew by —.
BibbInstruments' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.
BibbInstruments Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Margin | — | XXX | (3270%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 7% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 617% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 772% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 2286% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 3675% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
BibbInstruments Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| BibbInstruments | XXX | XXX | XXX | XXX | XXX | XXX |
| Zynex | XXX | XXX | XXX | XXX | XXX | XXX |
| AMA Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| enVVeno Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioretec | XXX | XXX | XXX | XXX | XXX | XXX |
| Pheton Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BibbInstruments M&A Activity
BibbInstruments acquired XXX companies to date.
Last acquisition by BibbInstruments was on XXXXXXXX, XXXXX. BibbInstruments acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by BibbInstruments
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBibbInstruments Investment Activity
BibbInstruments invested in XXX companies to date.
BibbInstruments made its latest investment on XXXXXXXX, XXXXX. BibbInstruments invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by BibbInstruments
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout BibbInstruments
| When was BibbInstruments founded? | BibbInstruments was founded in 2013. |
| Where is BibbInstruments headquartered? | BibbInstruments is headquartered in Sweden. |
| How many employees does BibbInstruments have? | As of today, BibbInstruments has over 5 employees. |
| Is BibbInstruments publicly listed? | Yes, BibbInstruments is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of BibbInstruments? | BibbInstruments trades under BIBB ticker. |
| When did BibbInstruments go public? | BibbInstruments went public in 2017. |
| Who are competitors of BibbInstruments? | BibbInstruments main competitors are Zynex, AMA Corp, enVVeno Medical, Bioretec. |
| What is the current market cap of BibbInstruments? | BibbInstruments' current market cap is $8M. |
| What is the current revenue of BibbInstruments? | BibbInstruments' last fiscal year revenue is $44K. |
| What is the current EV/Revenue multiple of BibbInstruments? | Current revenue multiple of BibbInstruments is 167.0x. |
| Is BibbInstruments profitable? | No, BibbInstruments is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.